Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Cancers × ridaforolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Endometrial Neoplasms 3 Sarcoma 2 Prostatic Neoplasms 2 Neoplasms 2 Breast Neoplasms 2 Recurrence 1 Primary Myelofibrosis 1 Osteosarcoma 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma 1 Liposarcoma 1 Leukemia 1 Leiomyosarcoma 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Cancers 1

Interventions

ridaforolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00836927 2019-02-18

MK-8669-038

Merck Sharp & Dohme LLC

Phase 2 Terminated

7 enrolled 13 charts

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡